Rufenacht, Daniel (SGS 202012 Group VP Corporate Communciations + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
Ruffieux, Pierre-Alain (Lonza 202011– CEO before Roche + Novartis + Serono) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
Ruge, Stefan (Bruker 200908 Managing Director Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
Ruggiero, Daniel (Merck (DE) 201808 Global Head Diabetes Strategy at Merck Biopharma business) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
Ruhe, Jens (Scimab GmbH 201611– Managing Director) |
Managing Director |
SciRhom GmbH |
Germany |
Ruile, Peter (MorphoSys 201106– Director Business Development before Ascenion GmbH COO) |
Business Development Manager / Strategy Manager |
MorphoSys (Group) |
Germany |
Ruiz, Stéphane (Actifin 201803) |
Public Relations Manager / Investor Relations Manager |
Actifin (FR) |
France |
Rujan, Tamas (Epigenomics 200605) |
n. a. |
Epigenomics (Group) |
Germany |
Rullkötter, Jürgen (Univ Oldenburg 201009 Professor and DirectorICBM) |
Professor |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
Rummelt, Andreas (InterPharmaLink 202011 CEO + Partner before Novartis + Sandoz) |
Chief Executive Officer (CEO) |
InterPharmaLink AG |
Switzerland |
Runge, Dieter (Primacyt Cell Culture Technology 201104 Managing Director) |
Managing Director |
Primacyt Cell Culture Technology GmbH |
Germany |
Ruoff, Michael (Think.Health Ventures 201812 Partner) |
Partner (venture partner) |
Think.Health GmbH (Think.Health Ventures) |
Germany |
Rupalla, Katrin (Ymmunobio 202206 CEO) |
Chief Executive Officer (CEO) |
Ymmunobio AG |
Switzerland |
Rusckowski, Steve (Quest Diagnostics 201205– CEO before Philips CEO of Philips Healthcare sector since 2006) |
Chief Executive Officer (CEO) |
Quest Diagnostics (Group) |
United States (USA) |
Russell, Simon (Creabilis 201205– CBO before Novartis Pharma AG + AstraZeneca + ICI Pharmaceuticals) |
Chief Business Officer (CBO) |
Creabilis (Group) |
Luxembourg |
Rutt, Antony (KDBio SAS 201704 President + Founder) |
President/Director/Head Business Group/Unit/Division |
KDBio S.A.S. |
France |
Rutten, Boyd (Gilde Investment 201903c– Senior Associate before EQT Partners) |
Investment Manager |
Gilde Investment (Group) |
Netherlands |
Rutten, Rolf Jan (Audion Therapeutics 201402 CEO) |
Chief Executive Officer (CEO) |
Audion Therapeutics (NL/US) |
Netherlands |
Rußwurm, Stefan (SIRS-Lab 200503) |
n. a. |
Endress+Hauser (Group) |
Germany |
Ryan, J. Michael (Asceneuron 201704 CMO) |
Chief Medical Officer (CMO) |
Asceneuron S.A. |
Switzerland |
Ryan, James (BioNTech 202309– Chief Legal Officer + Board Member before General Counsel + SVP Legal + IP joined 7/18) |
General Counsel / Chief Legal Officer (CLO) |
BioNTech (Group) |
Germany |
Rübenach, Susanne (Germany (govt) 201307 Investment Manager at ERP-Startfonds at KfW) |
Investment Manager |
Germany (govt) |
Germany |
Rübsamen-Schaeff, Helga (AiCuris 200603– before Bayer HealthCare anti-infectives research) |
Chief Executive Officer (CEO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Ryckebusch, Sylvie (Domain Therapeutics 202205 Non-executive Board Member) |
Board member, non-executive |
Domain Therapeutics (Group) |
France |
Rückle, Frank (Methrom 201301– Managing Director of Deutsche Methrom GmbH & Co KG joined 28 years before) |
Managing Director |
Metrohm (Group) |
Germany |
Rüdiger, Manfred (Ariceum Therapeutics 202206 CEO before Catalym + Affectis + Kiadis Pharma + LSP Munich) |
Chief Executive Officer (CEO) |
Ariceum Therapeutics (Group) |
Germany |
Rüegg, André (Bellevue Group 201409 CEO of Bellevue Asset Management) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
Ryffel, Theo (Arkhn 202105 Co-Founder) |
Company Founder |
Arkhn S.A.S. |
France |
Rüger, Simon (ZIM Plant Technology GmbH 201204 Managing Director) |
Managing Director |
ZIM Plant Technology GmbH |
Germany |
Rüger, Sven (Sovicell GmbH 201208 CFO) |
Chief Financial Officer (CFO) |
Sovicell GmbH |
Germany |
Rüggeberg, Hermann (Impetus GmbH 200902 Managing Director) |
Managing Director |
Impetus Bioscience (Group) |
Germany |
Rüggeberger, Hermann |
n. a. |
Impetus Bioscience (Group) |
Germany |
Rüsch, Jacqueline Ruedin (Privilège Ventures 202209 Founding General Partner) |
General Partner (venture partner) |
Privilège Ventures (CH) |
Switzerland |
Rüschmeier, Henner |
n. a. |
M.M. Warburg (Group) |
Germany |
Rüsenberg, Marcus |
n. a. |
Geneworx AG |
Germany |
Rüssmeier, Nick (Optimare 201204 Mechanical Engineering) |
Engineer |
Aerodata (Group) |
Germany |
Rüterjans, Heinz |
n. a. |
University of Frankfurt (Goethe-Universität) |
Germany |
Rüttinger, Dominik (Bayer 202110– Head of Research + Early Development for Oncology before Roche pRED + Micromet) |
Research & Development Manager |
Bayer (Group) |
Germany |
Räbiger, Thomas (BMG Labtech 201110 Managing Director) |
Managing Director |
BMG Labtech (Group) |
Germany |
Rädler, Ulf (ibidi 200311) |
n. a. |
ibidi GmbH |
Germany |
Röhr, Anneli |
n. a. |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
Röll, Marcel (Wave Biotech AG 200605 CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Switzerland |
Römer, Axel (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
Römer, Michael (Merck KGaA 200511) |
n. a. |
Merck (DE) (Group) |
Germany |
Rönicke, Susanne (RS Zelltechnik GmbH 201506 Managing Director) |
Managing Director |
RS Zelltechnik GmbH |
Germany |
Röpke, Werner (Techlab GmbH 201204 Managing Director) |
Managing Director |
Techlab GmbH |
Germany |
Rösch, Paul (Univ Bayreuth 201504 Professor at Research Center for Bio-Macromolecules) |
Professor |
University of Bayreuth |
Germany |
Röskamp, Jakob (Traceless Materials 202212 CFO) |
Chief Financial Officer (CFO) |
Traceless Materials GmbH |
Germany |
Rösler, Philipp (Germany (govt) Minister Economics + Technology before Health + Niedersachsen (govt) Minister Economics) |
Minister |
Germany (govt) |
Germany |
Rötger, Antje (Carpegen GmbH 201108 Managing Director) |
Managing Director |
Carpegen GmbH |
Germany |
Röver, Stephan (Roche 201006 Scientific Expert for Discovery Chemistry) |
Researcher (industry) |
Roche (Group) |
Switzerland |
Saalfeld, Sonja (Techlab GmbH 201204 Managing Director) |
Managing Director |
Techlab GmbH |
Germany |
Sabatin, Claude (France (govt) 201502 Innovation Representative at Bpifrance) |
n. a. |
France (govt) |
France |
Sablon, Erwin (Biocartis 201302 Head of Applied Assay Development) |
Research & Development Manager |
Biocartis (Group) |
Belgium |
Sabry, James H. (Roche 201808– Global Head Partnering joined Genentech 2010 before Arete Therapeutics + Cytokinetics) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
Sabzevari, Helen (Intrexon 202001– CEO joined 2017 formerly Merck Serono) |
Chief Executive Officer (CEO) |
Precigen (Group) |
United States (USA) |
Sachse, Christoph (Univ Tübingen 201504– Site Head Berlin NMI TT Pharmaservices before siTools + Cenix BioScience) |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Sachsenmaier, Christoph (Epimune GmbH 201805 BusDev before Ribolution Health + Epigenomics + ApoCell + Beckman Coulter) |
Business Development Manager / Strategy Manager |
Epimune GmbH |
Germany |
Sack, Stephan (Harlan Laboratories 200910 Manager Analytical Services at Harlan Laboratories Ltd) |
Laboratory Manager (industry) |
Envigo (Group) |
Switzerland |
Sackers, Roland (Qiagen 200408 CFO) |
Chief Financial Officer (CFO) |
Qiagen (Group) |
Netherlands |
Sadiq, Kashif (DenovAI Biotech 202302– CEO + Co-Founder before EMBL) |
Chief Executive Officer (CEO) |
DenovAI Biotech (IL/DE) |
Israel |
Sadler, Penny (Coulter Partners 201911– Head of Brussels office before Spencer Stuart + Korn Ferry) |
Chief Operating Officer (COO) |
Coulter Partners, Brussels |
Belgium |
Sadtler, Stefan (Sarstedt 201705 Director of Marketing Life Science) |
Sales Manager / Marketing Manager |
Sarstedt (Group) |
Germany |
Sagaert, Bernard (eTheRNA 202208– Interim-CEO before COO) |
Chief Executive Officer (CEO) |
eTheRNA (Group) |
Belgium |
Sagar, Bijoy (Bayer 202301 Chief Information + Digital Transformation Officer) |
Chief Information Officer (CIO) / Chief Digital Officer |
Bayer (Group) |
Germany |
Sager, Cédric (Debiopharm 201403 CEO of Debiopharm Research & Manufacturing SA) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Switzerland |
Sagmeister, Bernhard (Austria (govt) 201107 Managing Director of aws) |
Managing Director |
Austria (govt) |
Austria |
Sahasrabudhe, Priyanka (Navigo Proteins 202309 Senior Business Development Manager) |
Business Development Manager / Strategy Manager |
UV-Cap (Vetter family office) (Group) |
Germany |
Sahin, Gencer (Hamburg (govt) 201603 Investment Manager at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH) |
Managing Director |
BioNTech (Group) |
Germany |
Said, Maya (Transgene 201706– Non-Executive Board Member before Novartis + Sanofi + Boston Consulting) |
Board member, non-executive |
Mérieux (Group) |
France |
Sainsot, Alain (Amatsigroup 201601 Chairman) |
Board member |
Eurofins (Group) |
France |
Salahdine, Younes (NeraCare 202005 Director of Corporate Development) |
Business Development Manager / Strategy Manager |
NeraCare GmbH |
Germany |
Salauze, Damien (Institut Curie 201412 Director at Curie-Cancer) |
President/Director/Head of Research Organisation/Unit |
Institut Curie |
France |
Sallam, Ahmed (Cysal GmbH 201210– Managing Director + Co-founder) |
Managing Director |
Cysal GmbH |
Germany |
Salles, Jean-Pierre (Provence Technologies 201406– Executive Management of Provepep before Founder of Synprosis) |
Board member, executive |
Provence Technologies (Group) |
France |
Salot, Samuel (Cynbiose 201801– General Manager at Cynbiose Respiratory) |
General Manager (management) |
Cynbiose (Group) |
France |
Salzman, Amber (Epic Bio 202207 CEO before Annapurna Therapeutics + Cardiokine) |
Chief Executive Officer (CEO) |
Epic Bio (Epicrispr Biotechnologies, Inc.) |
United States (USA) |
Salzmann, Michael (Neurimmune 2008– COO + General Manager before Bruker + Roche + ETH Zürich) |
Chief Operating Officer (COO) |
Neurimmune AG |
Switzerland |
Samama, Laurent (Jolt Capital 202211 Managing Partner) |
Managing Partner |
Jolt Capital S.A.S. |
France |
Sameith, Janin (Hessen (govt) 202001 Senior Project Manager Life Sciences + Biobased Economy at Technologieland Hessen |
Cluster Manager |
Hessen (Hesse) (govt region) |
Germany |
Sampath, Rangarajan (Siemens 202112 Head of Center for Innovation in Diagnostics at Siemens Healthineers) |
President/Director/Head of Research Organisation/Unit |
Siemens (Group) |
Germany |
Sampers, Thomas (Renolit 202005 Head of Renolit Healthcare) |
President/Director/Head Business Group/Unit/Division |
Renolit (Group) |
Germany |
Sampson, Hugh (DBV Technologies 201802 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
DBV Technologies S.A. (Euronext Paris: DBV + Nasdaq Global Select Market: DBVT) |
France |
Sanchez, Jean-Charles (Univ Geneva 201204 Professor + Director Biomedical Proteomics Research Group) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
Sanctorum, Hermes (Paleo 202302 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Paleo B.V. |
Belgium |
Sand, Roland (Glycotope 201601 Board Chairman) |
Board member, non-executive |
Glycotope (Group) |
Germany |
Sandbrink, Rupert (Topas Therapeutics 201710– CDO + CMO before Forward Pharma A/S + Bayer AG + Schering AG) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Topas Therapeutics GmbH |
Germany |
Sander, Stephan (Fassisi 201102 Managing Director) |
Managing Director |
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH |
Germany |
Sanders, Alan (Bruker 201511 Director of Marketing at Bruker Detection) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
Sanders, Bart (Stentit 202204 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Stentit B.V. |
Netherlands |
Sanders, Heiner (Alpha Metrix Biotech 200512) |
n. a. |
Alpha Metrix Biotech GmbH |
Germany |
Sanders, Maja (Cergentis 202006– Non-executive Board Director) |
Board member, non-executive |
Solvias (Group) |
Netherlands |
Sandig, Volker (ProBioGen 201004 promoted CSO since 2000 at ProBiogGen before Merck US) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Minapharm (Group) |
Germany |
Sandin, Mary Beth (Affimed 202101 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
Sandin, Mary Beth (Affimed 202204 VP Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
Sandler, Andrew (Kiadis 201710– CMO before Medivation + Dendreon Pharmaceuticals + Spectrum Pharma) |
Chief Medical Officer (CMO) |
Kiadis (Group) |
Netherlands |
Sandokchi, Soraya (Flash Therapeutics 202307 Head of Communication) |
Public Relations Manager / Investor Relations Manager |
Flash Therapeutics S.A.S. |
France |
Sandor, Victor (ADC Therapeutics 202004– Board Director before CMO at Array BioPharma + Incyte + Biogen Idec + AZ) |
Board member, non-executive |
ADC Therapeutics (Group) |
Switzerland |
Sandra, Koen (Research Institute for Chromatography) |
Research & Development Manager |
Research Institute for Chromatography (R.I.C.) (Group) |
Belgium |